Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 26 Mar 24 424B3 Prospectus supplement
- 5 Feb 24 424B3 Prospectus supplement
- 15 Dec 23 424B3 Prospectus supplement
- 26 Sep 23 424B3 Prospectus supplement
- 15 Jun 23 424B4 Prospectus supplement with pricing info
- 14 Jun 23 EFFECT Notice of effectiveness
- 12 Jun 23 S-1/A IPO registration (amended)
- 6 Jun 23 S-1/A IPO registration (amended)
- 31 May 23 S-1/A IPO registration (amended)
- 26 Apr 23 S-1/A IPO registration (amended)
-
15 Feb 23 S-1 IPO registration
COEP similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 10, 2022 with respect to the consolidated financial statements of Coeptis Therapeutics Holdings, Inc. (formerly Coeptis Therapeutics, Inc.) contained in the Form S-1 Registration Statement of Coeptis Therapeutics Holding, Inc. We consent to the use of our aforementioned report in the Form S-1 Registration Statement, and to the use of our name as it appears under the caption “Experts.”
/s/ TURNER, STONE & COMPANY, LLP
Dallas, Texas
February 14, 2023